Skip to main content
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
17.43
-0.34 (-1.91%)
Nov 13, 2026, 4:00 PM EST - Market closed

Arcus Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-453-353-283-307-26753
Depreciation & Amortization
101010864
Asset Writedown & Restructuring Costs
--20---
Loss (Gain) From Sale of Investments
-10-13-25-19-5
Stock-Based Compensation
656076736555
Other Operating Activities
1081010113
Change in Accounts Receivable
2392815704-17
Change in Accounts Payable
2243-18-5
Change in Unearned Revenue
-89-240-56-68-112-368
Change in Other Net Operating Assets
-231347-172314
Operating Cash Flow
-465-482-170-306438-256
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1-2-6-24-6-26
Investment in Securities
6768-78218-40422
Other Investing Activities
-----3-
Investing Cash Flow
6666-84194-413-4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-4947---
Net Debt Issued (Repaid)
-4947---
Issuance of Common Stock
3124392373323232
Repurchase of Common Stock
---7---
Other Financing Activities
----105
Financing Cash Flow
3124882773333237

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-877223-7958-23

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-466-484-176-330432-282
Free Cash Flow Growth
------
Free Cash Flow Margin
-466.00%-195.95%-68.22%-282.05%385.71%-73.63%
Free Cash Flow Per Share
-3.75-4.51-1.95-4.466.00-3.81
Levered Free Cash Flow
-274.75-162.25-41.25-187.75617.75-644.75
Unlevered Free Cash Flow
-267.88-157.25-38.75-186.5619-644.75

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
771---
Cash Income Tax Paid
---53-
Change in Working Capital
-87-19422-71623-376
SEC Filings: 10-K · 10-Q